Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
525.19
-13.10 (-2.43%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,266,121
Open
536.00
Bid (Size)
516.58 (1)
Ask (Size)
525.79 (8)
Prev. Close
538.29
Today's Range
516.57 - 537.34
52wk Range
302.14 - 601.84
Shares Outstanding
N/A
Dividend Yield
0.86%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Eli Lilly Stock Was Looking Sickly Today
October 03, 2023
Investors weren't necessarily satisfied with their company's latest asset buy.
Via
The Motley Fool
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
October 03, 2023
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Performance
YTD
+43.89%
+43.89%
1 Month
-5.91%
-5.91%
3 Month
+12.77%
+12.77%
6 Month
+48.10%
+48.10%
1 Year
+63.33%
+63.33%
More News
Read More
Why Eli Lilly Stock Is Trading Lower Today
October 03, 2023
Via
Benzinga
Why Shares of Point Biopharma Global Are Soaring Tuesday
October 03, 2023
Via
The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
Via
Benzinga
Analyst Ratings for Eli Lilly
October 02, 2023
Via
Benzinga
FDA Declines To Approve Eli Lilly's Eczema Drug
October 02, 2023
Via
Benzinga
Exposures
Product Safety
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 03, 2023
Via
Benzinga
Nasdaq Down Over 200 Points; US Job Openings Rise In August
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Point Biopharma Stock Nearly Doubles On Eli Lilly Deal
October 03, 2023
Via
Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS)
October 03, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
S&P 500 Forecast: Stocks Drop As Treasury Yields Surge
October 03, 2023
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Via
Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Falls Over 100 Points; McCormick Sales Miss Views
October 03, 2023
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover
October 03, 2023
Via
Investor's Business Daily
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
October 03, 2023
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
Via
Benzinga
Why Is Point Biopharma (PNT) Stock Up 84% Today?
October 03, 2023
Via
InvestorPlace
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
October 03, 2023
Via
Investor's Business Daily
Why Shares of Structure Therapeutics Are Up Monday
October 02, 2023
Via
The Motley Fool
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
Via
InvestorPlace
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
October 02, 2023
Via
InvestorPlace
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
October 02, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Product Safety
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.